Our Story Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Partnering Advisory Board

Pipeline Overview Otenaproxesul (ATB-346) ATB-352 Emerging Discovery Program

Our Science Current Solutions for Acute Pain Why Hydrogen Sulfide? Scientific Publications References

Dashboard Corporate Presentation Financials Regulatory Filings Governance

News Events In the Media

2020 AGM

2020 Annual General Meeting - Notice and Circular

Home
/
2020 AGM

Please click to access the 2020 AGM Notice and Circular.

TARGETING INFLAMMATION

Cookies Policy
Legal Terms
Privacy Policy
Contact Us
TSX:ATE
OTCQX:ATBPF

© 2023 Antibe Therapeutics Inc. All rights reserved.

We use cookies to ensure you get the best experience on our website. Learn more about our privacy policy.

Attention

This is an external link. Click “OK” to continue.

Perspectives